Figure 1 | Scientific Reports

Figure 1

From: Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion

Figure 1

Fluctuations in MPE and intrathoracic MPE progression-free survival in patients with different treatments. (a) Fluctuation of the maximum MPE detected by B-ultrasound before and after first-line treatment. (b) Intrathoracic MPE progression-free survival in patients treated with TKIs, chemotherapy, or palliative care treatment. ((c) and (d)) Impact of local treatment on MPE progression-free survival in patients treated with TKIs (c) or palliative care (d) in subgroup analysis. MPE malignant pleural effusions, TKI tyrosine kinase inhibitor, HITHOC hyperthermic intrathoracic chemotherapy, IPCD indwelling pleural catheter drainage.

Back to article page